Tianhong Li

Tianhong Li, MD, PhD

UC Davis Health

Session Chair

Biography

Tianhong “Tina” Li, MD, PhD, serves as a Professor of Clinical Medicine and thoracic medical oncologist at both the UC Davis Comprehensive Cancer Center (UCDCCC) and the VA Northern California Health Care System (VANCHCS). Dr. Li's expertise lies in personalized cancer care, drawing upon her extensive background in laboratory and clinical research. Currently, she holds the position of Phase I Disease Team Leader at UCDCCC, where she leads efforts to translate innovative treatment strategies and technological advancements into direct patient care through early phase clinical trials. Supported by grants from the NIH and the Office of Research & Development, her laboratory research focuses on generating novel cancer therapies and improving tissue and blood-based molecular and immune biomarkers for precision lung cancer therapy. Furthermore, Dr. Li has served as a Principal Investigator in numerous investigator-initiated, multicenter clinical trials, as well as industry-supported phase II-III clinical trials investigating novel immunotherapies for lung cancer. She received the recognition of "Best Doctors in Sacramento" from Sacramento Magazine in 2020 and 2022.

Financial Disclosure

Amgen

Grant Or Contract

AstraZeneca

Grant Or Contract

Duality Biologics

Grant Or Contract

LabyRx Immuno-oncology

Grant Or Contract

RasCal Therapeutics

Grant Or Contract

Tempus

Grant Or Contract

Xilio Therapeutics

Grant Or Contract

BMS

Grant Or Contract

Chugai Pharma

Grant Or Contract

Marengo

Grant Or Contract

Genentech/LaRoche

Grant Or Contract

OncoC4/BioNTech

Grant Or Contract

Novartis

Grant Or Contract